The use of hydrocortisone in cancer.

Abstract

Annals of the New York Academy of SciencesVolume 61, Issue 2 p. 393-396 THE USE OF HYDROCORTISONE IN CANCER O. H. Pearson, O. H. Pearson Division of Clinical Investigation, Sloan-Kettering, Institute for Cancer Research, and the Department of Medicine, Memorial and James Ewing Hospitals, New York, N.Y.Search for more papers by this authorM. C. Li, M. C. Li Division of Clinical Investigation, Sloan-Kettering, Institute for Cancer Research, and the Department of Medicine, Memorial and James Ewing Hospitals, New York, N.Y.Search for more papers by this authorJ. P. Maclean, J. P. Maclean Division of Clinical Investigation, Sloan-Kettering, Institute for Cancer Research, and the Department of Medicine, Memorial and James Ewing Hospitals, New York, N.Y.Search for more papers by this authorM. B. Lipsett, M. B. Lipsett Division of Clinical Investigation, Sloan-Kettering, Institute for Cancer Research, and the Department of Medicine, Memorial and James Ewing Hospitals, New York, N.Y.Search for more papers by this authorC. D. West, C. D. West Division of Clinical Investigation, Sloan-Kettering, Institute for Cancer Research, and the Department of Medicine, Memorial and James Ewing Hospitals, New York, N.Y.Search for more papers by this author O. H. Pearson, O. H. Pearson Division of Clinical Investigation, Sloan-Kettering, Institute for Cancer Research, and the Department of Medicine, Memorial and James Ewing Hospitals, New York, N.Y.Search for more papers by this authorM. C. Li, M. C. Li Division of Clinical Investigation, Sloan-Kettering, Institute for Cancer Research, and the Department of Medicine, Memorial and James Ewing Hospitals, New York, N.Y.Search for more papers by this authorJ. P. Maclean, J. P. Maclean Division of Clinical Investigation, Sloan-Kettering, Institute for Cancer Research, and the Department of Medicine, Memorial and James Ewing Hospitals, New York, N.Y.Search for more papers by this authorM. B. Lipsett, M. B. Lipsett Division of Clinical Investigation, Sloan-Kettering, Institute for Cancer Research, and the Department of Medicine, Memorial and James Ewing Hospitals, New York, N.Y.Search for more papers by this authorC. D. West, C. D. West Division of Clinical Investigation, Sloan-Kettering, Institute for Cancer Research, and the Department of Medicine, Memorial and James Ewing Hospitals, New York, N.Y.Search for more papers by this author First published: May 1955 https://doi.org/10.1111/j.1749-6632.1955.tb42489.xCitations: 33 These studies were supported by grants from the National Cancer Institute, National Institutes of Health, United States Public Health Service, Bethesda, Med., C925 (C5); the United States Atomic Energy Commission; The Damon Runyon Memorial Fund, New York, N. Y., The American Cancer Society, New York, N. Y.; and the Lillian Babbitt Hyde Foundation, New York, N. Y. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume61, Issue2Hydrocortisone, its Newer Analogs and Aldosterone as Therapeutic AgentsMay 1955Pages 393-396 RelatedInformation